Kapiva, an India-based ayurveda healthcare products company, has raised US$60 million in series D funding.

The round was led by 360 ONE Asset and Vertex Growth, with participation from existing investors Vertex Ventures Southeast Asia and India and 3one4 Capital.

Of the total, US$28 million was primary capital, while the rest provided exits for some early investors.

Kapiva said it plans to use the funds for R&D, manufacturing, brand investments, and developing a health-tech platform for personalized care.

🔗 Source: YourStory